---
schema_version: "secwatch.filing_event.v1"
accession: "0000078003-23-000085"
form_type: "8-K"
ticker: "PFE"
cik: "0000078003"
company_name: "PFIZER INC"
filed_at: "2023-08-01T23:59:59+00:00"
generated_at: "2026-06-12T19:44:57.822495+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Pfizer Q2 revenues $12.7B (-54% YoY); narrows FY revenue guidance to $67-70B

## Summary
- Q2 reported diluted EPS $0.41 (-77% YoY); adjusted diluted EPS $0.67 (-67% YoY).
- Comirnaty and Paxlovid combined revenue $1.6B; ex-COVID revenue grew 5% operationally.
- Narrowed FY2023 revenue guidance to $67-70B (previously $67-71B); maintained adjusted EPS guidance $3.25-3.45.
- Non-COVID operational growth expectation reduced to 6-8% from 7-9% due to label, ACIP recommendation, tornado damage.
- Closed $31B debt offering to partly fund Seagen acquisition; transaction expected late 2023/early 2024.

## SEC filing metadata
- accession: 0000078003-23-000085
- form_type: 8-K
- ticker: PFE
- cik: 0000078003
- company_name: PFIZER INC
- filed_at: 2023-08-01T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/78003/000007800323000085/0000078003-23-000085-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/78003/000007800323000085/pfe-20230801.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000078003-23-000085
- JSON: https://secwatch.observer/filing/0000078003-23-000085.json
- Plain text: https://secwatch.observer/filing/0000078003-23-000085.txt

## Key facts
- Earnings Releases
  PFIZER INC reported the second quarter of 2023 results: revenue $12,734, net income $2,327, EPS $0.41. Guidance reaffirmed.
  - Period: the second quarter of 2023
  - Revenue: $12,734
  - Net income: $2,327
  - EPS: $0.41
  - Guidance: reaffirmed
  - Result: reported results
  source text: of 2023 and 2022 (5) are summarized below. OVERALL RESULTS ($ in millions, except per share amounts) Second-Quarter Six Months 2023 2022 Change 2023 2022 Change Revenues $ 12,734 $ 27,742 (54%) $ 31,015 $ 53,402 (42%) Reported Net Income (2) 2,327 9,906 (77%) 7,870 17,769 (56%) Reported Diluted EPS (2) 0.41 1.73 (77%) 1.38 3.10 (56%) Adjusted (3) Income
  evidence_url: https://www.sec.gov/Archives/edgar/data/78003/000007800323000085/0000078003-23-000085-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.